169 related articles for article (PubMed ID: 32271809)
61. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF
Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469
[TBL] [Abstract][Full Text] [Related]
62. Benchmark study of automatic annotation of MALDI-TOF N-glycan profiles.
Brito AE; Kletter D; Singhal M; Bern M
J Proteomics; 2015 Nov; 129():71-77. PubMed ID: 26047718
[TBL] [Abstract][Full Text] [Related]
63. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.
Mendrinos S; Nolen JD; Styblo T; Carlson G; Pohl J; Lewis M; Ritchie J
Cancer; 2005 Jun; 105(3):178-83. PubMed ID: 15822128
[TBL] [Abstract][Full Text] [Related]
64. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X
Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203
[TBL] [Abstract][Full Text] [Related]
65. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
[TBL] [Abstract][Full Text] [Related]
66. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
[TBL] [Abstract][Full Text] [Related]
67. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
[TBL] [Abstract][Full Text] [Related]
68. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
[TBL] [Abstract][Full Text] [Related]
69. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
[TBL] [Abstract][Full Text] [Related]
70. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.
Akimoto Y; Nouso K; Kato H; Miyahara K; Dohi C; Morimoto Y; Kinugasa H; Tomoda T; Yamamoto N; Tsutsumi K; Kuwaki K; Onishi H; Ikeda F; Nakamura S; Shiraha H; Takaki A; Okada H; Amano M; Nishimura S; Yamamoto K
Pancreatology; 2015; 15(4):432-8. PubMed ID: 26052067
[TBL] [Abstract][Full Text] [Related]
71. MALDI-TOF serum protein profiling for the detection of breast cancer.
de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
[TBL] [Abstract][Full Text] [Related]
72. Automated measurement of permethylated serum N-glycans by MALDI-linear ion trap mass spectrometry.
Guillard M; Gloerich J; Wessels HJ; Morava E; Wevers RA; Lefeber DJ
Carbohydr Res; 2009 Aug; 344(12):1550-7. PubMed ID: 19577739
[TBL] [Abstract][Full Text] [Related]
73. High-throughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jeong HJ; Kim YG; Yang YH; Kim BG
Anal Chem; 2012 Apr; 84(7):3453-60. PubMed ID: 22455307
[TBL] [Abstract][Full Text] [Related]
74. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R
Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488
[TBL] [Abstract][Full Text] [Related]
75. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS.
Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG
Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729
[TBL] [Abstract][Full Text] [Related]
76. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
77. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
78. N-glycosylation analysis by HPAEC-PAD and mass spectrometry.
Kandzia S; Costa J
Methods Mol Biol; 2013; 1049():301-12. PubMed ID: 23913225
[TBL] [Abstract][Full Text] [Related]
79. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
80. N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.
Chen J; Fang M; Chen X; Yi C; Ji J; Cheng C; Wang M; Gu X; Sun Q; Gao C
BMC Cancer; 2017 Dec; 17(1):881. PubMed ID: 29268706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
